Review
doi: 10.1016/j.ymeth.2012.03.016.
Epub 2012 Mar 23.
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
Affiliations
- PMID: 22465793
- DOI: 10.1016/j.ymeth.2012.03.016
Item in Clipboard
Review
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
Methods.
2012 Apr.
Abstract
The need for improved diagnostic accuracy and markers of progression in neurodegenerative diseases motivates the identification of objective biomarkers as well as optimized assays for their quantification. Several potential marker candidates for Parkinson's disease (PD) in cerebrospinal fluid have been identified. These include α-synuclein, a major constituent of the intracellular aggregates. We give a general overview and details of our experience in converting established enzyme-linked immunoabsorbent assays (for α-synuclein and other proteins) onto an electrochemiluminescence-based platform as well as considerations on multiplexing different assays for PD.
Copyright © 2012. Published by Elsevier Inc.
Similar articles
-
Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid.Bioanalysis. 2017 Apr;9(8):621-630. doi: 10.4155/bio-2017-0005. Epub 2017 May 15. Bioanalysis. 2017. PMID: 28504552
-
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.Mov Disord. 2011 Jul;26(8):1428-35. doi: 10.1002/mds.23670. Epub 2011 Apr 5. Mov Disord. 2011. PMID: 21469206
-
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based Detection.Methods Mol Biol. 2019;1948:59-68. doi: 10.1007/978-1-4939-9124-2_6. Methods Mol Biol. 2019. PMID: 30771170
-
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.Biomark Med. 2010 Oct;4(5):683-99. doi: 10.2217/bmm.10.90. Biomark Med. 2010. PMID: 20945981 Review.
-
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.Biomark Med. 2016;10(1):35-49. doi: 10.2217/bmm.15.107. Epub 2015 Dec 8. Biomark Med. 2016. PMID: 26643452 Review.
Cited by
-
Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects.Clin Proteomics. 2017 Jul 25;14:28. doi: 10.1186/s12014-017-9163-z. eCollection 2017. Clin Proteomics. 2017. PMID: 28769740 Free PMC article.
-
Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.Ann Rheum Dis. 2017 Nov;76(11):1890-1896. doi: 10.1136/annrheumdis-2017-211384. Epub 2017 Aug 16. Ann Rheum Dis. 2017. PMID: 28814432 Free PMC article.
-
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.PLoS Genet. 2014 Nov 13;10(11):e1004741. doi: 10.1371/journal.pgen.1004741. eCollection 2014 Nov. PLoS Genet. 2014. PMID: 25393002 Free PMC article.
-
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.Mol Cell Proteomics. 2016 Oct;15(10):3126-3138. doi: 10.1074/mcp.M116.059915. Epub 2016 Aug 9. Mol Cell Proteomics. 2016. PMID: 27507836 Free PMC article.
-
Natural product-based pharmacological studies for neurological disorders.Front Pharmacol. 2022 Nov 7;13:1011740. doi: 10.3389/fphar.2022.1011740. eCollection 2022. Front Pharmacol. 2022. PMID: 36419628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
